Cargando…
Smooth or Risky Revisit of an Old Malaria Drug for COVID-19?
Hydroxychloroquine (HCQ) is an old medication for malaria. In addition to handling this parasitic disease, HCQ is also used to treat a number of autoimmune disorders including rheumatoid arthritis and systemic lupus erythematosus when other medications are not effective. Recently a new viral infecti...
Autores principales: | Pahan, Priyanka, Pahan, Kalipada |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225253/ https://www.ncbi.nlm.nih.gov/pubmed/32415419 http://dx.doi.org/10.1007/s11481-020-09923-w |
Ejemplares similares
-
Is COVID-19 Gender-sensitive?
por: Mukherjee, Shreya, et al.
Publicado: (2021) -
Comment on “Smooth or Risky Revisit of an Old Malaria Drug for COVID-19?”
por: Cure, Erkan, et al.
Publicado: (2020) -
Can cinnamon bring aroma in Parkinson's disease treatment?
por: Pahan, Priyanka, et al.
Publicado: (2015) -
Prospects of Cinnamon in Multiple Sclerosis
por: Pahan, Kalipada
Publicado: (2015) -
Gemfibrozil, a Lipid-Lowering Drug, Lowers Amyloid Plaque Pathology and Enhances Memory in a Mouse Model of Alzheimer’s Disease via Peroxisome Proliferator-Activated Receptor α
por: Chandra, Sujyoti, et al.
Publicado: (2019)